Precigen (PGEN) FY2024 results: revenue $4 million, down 36.9% on the year
Precigen, Inc. (PGEN) reported revenue of $4 million for fiscal 2024, the year ended 31 December 2024, down 36.9% on the year before. Net income was -$126 million, and diluted earnings per share $-0.47. The figures are the company's own, from the 10-K it filed with the SEC on 25 March 2026.
Revenue
$4 million
-36.9% on the year
FY2017FY2024
Operating margin
-3440.2%
-1602.5% a year earlier
FY2017FY2024
Net income
-$126 million
FY2017FY2024
Diluted EPS
-$0.47
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Revenue
3.9
6.2
26.9
-36.9%
Research and development
53.1
48.6
n/a
+9.2%
Selling, general and administrative
41.3
40.4
n/a
+2.2%
Operating income
-135
-99.8
n/a
Operating margin
-3440.2%
-1602.5%
n/a
Interest expense
0.0
0.5
n/a
-98.7%
Pre-tax income
-128
-96.4
-80.0
Income tax
-1.8
-0.5
-0.2
Net income
-126
-95.9
28.3
Net margin
-3216.2%
-1540.6%
105.2%
Diluted EPS
-$0.47
-$0.39
$0.14
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
-68.2
-66.9
-65.0
Capital expenditure
8.6
1.5
4.9
+458.9%
Free cash flow
-76.8
-68.5
-70.0
Free cash flow margin
-1955.6%
-1099.9%
-260.0%
Cash from investing
-20.7
-3.1
226
Cash from financing
111
29.6
-155
+273.7%
Depreciation and amortisation
4.5
6.7
10.8
-32.1%
Share-based compensation
9.5
9.9
10.2
-4.2%
Diluted shares, weighted
268m
245m
200m
+9.5%
Shares outstanding at period end
107m
249m
208m
-57.0%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
38.5
118
126
-67.5%
Redeemable equity
28.2
0.0
0.0
Short-term borrowings
n/a
n/a
43.2
Debt
0.0
0.0
43.2
Operating lease liabilities
4.5
5.9
7.0
-22.9%
Other liabilities
74.0
26.6
n/a
+177.6%
Total liabilities and equity
145
151
216
-3.8%
Fixed assets
13.8
7.1
7.3
+94.5%
Goodwill
19.1
26.6
36.9
-28.1%
Intangible assets
4.5
40.7
44.5
-89.1%
Investments
68.4
55.3
51.1
+23.7%
Cash and equivalents
29.5
7.6
4.9
+289.5%
Receivables
0.9
0.9
1.0
+2.7%
Other assets
9.0
12.9
70.3
-30.0%
Total assets
145
151
216
-3.8%
10-K for the year ended 31 December 2024, filed 25 March 2026: the filing.